TITLE

Therapeutic outcome of patients suffering from malignant melanomas of the conjunctiva

AUTHOR(S)
Lommatzsch, P. K.; Lommatzsch, R. E.; Kirsch, I.; Fuhrmann, P.
PUB. DATE
October 1990
SOURCE
British Journal of Ophthalmology;Oct1990, Vol. 74 Issue 10, p615
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66096028

 

Related Articles

  • cme QUIZ.  // Journal of Pediatric Ophthalmology & Strabismus;Sep2007, Vol. 44 Issue 5, p298 

    A quiz about malignant melanoma of the conjunctiva in children is presented.

  • Multilocular sinonasal malignant melanoma: a poor prognostic subgroup? Stanimirov Rossi, O.; Vital, Domenic; Soyka, M.; Roth, T.; Huber, G.; Holzmann, D. // European Archives of Oto-Rhino-Laryngology;Jan2015, Vol. 272 Issue 1, p123 

    Clinical observations show that two subtypes of sinonasal malignant melanoma exist: uni- and multilocular melanoma. The aim of this retrospective study was to determine the prevalence and outcome of multilocular sinonasal malignant melanoma. All patients with sinonasal malignant melanoma treated...

  • Conjunctival malignant melanoma in xeroderma pigmentosum - a case report. Sharma, Saurabh; Bassi, Roopam // Journal of Pakistan Association of Dermatologists;Oct-Dec2011, Vol. 21 Issue 4, p289 

    Xeroderma pigmentosum (XP) is a rare autosomal recessive disease characterised by photosensitivity, pigmentary changes, premature skin ageing and development of various cutaneous and internal malignancies at an early age due to defective nucleotide excision repair following exposure to...

  • Conjuctival Melanomas. Arif, Nigar Niki; Henkind, Paul // Journal of Dermatologic Surgery & Oncology;May79, Vol. 5 Issue 5, p369 

    There is no known biologic difference between melanocytes in the conjunctiva and those in the skin. Presumably then, there is no distinction between nevi and the melanomas that develop from them. Invasive conjunctival malignant melanomas are commonly extensions from intraepithelial melanomas,...

  • Biochemotherapy Gets Thumb's Down. Helwick, Caroline // Dermatology Times;Aug2003, Vol. 24 Issue 8, p33 

    Discusses the inecffectivity of biochemotherapy for stage four malignant melanoma. Improvement of outcomes for patients with metastatic disease; Benefits from augmentation with interferon alpha and interleukin-2; Approaches in treating patients with stage four melanoma.

  • Patterns of regional head and neck lymph node metastasis in primary conjunctival malignant melanoma. Lim, M.; Tatla, T.; Hersh, D.; Hungerford, J. // British Journal of Ophthalmology;Dec2006, Vol. 90 Issue 12, p1468 

    Objective: To correlate patterns of regional lymph node metastasis with the site of origin in primary conjunctival malignant melanoma. Design: Retrospective analysis (1990-2003) of clinical data. Setting: Two London tertiary referral centres. Participants: 12 patients presenting with regional...

  • Number of People Living with Drug-Treatable Unresectable Malignant Melanoma Will Increase by 46% by 2025.  // Biomedical Market Newsletter;10/17/2011, Vol. 21, p73 

    The article focuses on an analysis of the Pharmacor Patient Flow Model Malignant Melanoma conducted by Decision Resources Inc. which predicts that there will be a 46% increase in the number of people worldwide suffering from malignant melanoma in 2025. The analysis also discovers that there will...

  • Malignant Melanoma in the 21st Century: The Emerging Molecular Landscape. Sekulic, Aleksandar; Haluska Jr, Paul; Miller, Arlo J.; De Lamo, Josep Genebriera; Ejadi, Samuel; Pulido, Jose S.; Salomao, Diva R.; Thorland, Erik C.; Vile, Richard G.; Swanson, David L.; Pockaj, Barbara A.; Laman, Susan D.; Pittelkow, Mark R.; Markovic, Svetomir N. // Mayo Clinic Proceedings;Jul2008, Vol. 83 Issue 7, p825 

    Malignant melanoma presents a substantial clinical challenge. Current diagnostic methods are limited In their ability to diagnose early disease and accurately predict Individual risk of disease progression and outcome. The lack of adequate approaches to properly define disease subgroups...

  • Conjunctival Amelanotic Melanoma - A Case Report. Kovačević, Damir; Lukanović-Primc, Koraljka; Markušić, Vedran; Babić, Marijana Bilen; Ledić, Darko // Collegium Antropologicum;Jun2011 Supplement, Vol. 35, p295 

    Conjunctival melanoma is a relatively rare malignancy. It is presented as pigmented nodule in any area of conjunctiva, amelanotic tumors are pink with smooth apperance. The authors describe an amelanotic melanoma of the conjunctiva in an 82-year-old female patient. Cytological, histopathological...

  • Malignant Melanoma and Subsequent Other Malignancies. Shafir, Raphael // Journal of Dermatologic Surgery & Oncology;Jul78, Vol. 4 Issue 7, p531 

    This report describes two young man who suffered from cutaneous malignant melanomas and subsequently other malignancies, namely adrenal in one and testicular in the other.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics